321 related articles for article (PubMed ID: 37542852)
1. The impact of microbiota-derived short-chain fatty acids on macrophage activities in disease: Mechanisms and therapeutic potentials.
Duan H; Wang L; Huangfu M; Li H
Biomed Pharmacother; 2023 Sep; 165():115276. PubMed ID: 37542852
[TBL] [Abstract][Full Text] [Related]
2. The effect of short-chain fatty acids on M2 macrophages polarization in vitro and in vivo.
Huang C; Du W; Ni Y; Lan G; Shi G
Clin Exp Immunol; 2022 Jan; 207(1):53-64. PubMed ID: 35020860
[TBL] [Abstract][Full Text] [Related]
3. Anticancer Effects of Gut Microbiota-Derived Short-Chain Fatty Acids in Cancers.
Son MY; Cho HS
J Microbiol Biotechnol; 2023 Jul; 33(7):849-856. PubMed ID: 37100764
[TBL] [Abstract][Full Text] [Related]
4. Gut microbiota-derived short-chain fatty acids promote prostate cancer progression via inducing cancer cell autophagy and M2 macrophage polarization.
Liu Y; Zhou Q; Ye F; Yang C; Jiang H
Neoplasia; 2023 Sep; 43():100928. PubMed ID: 37579688
[TBL] [Abstract][Full Text] [Related]
5. The metabolite butyrate produced by gut microbiota inhibits cachexia-associated skeletal muscle atrophy by regulating intestinal barrier function and macrophage polarization.
Liu H; Xi Q; Tan S; Qu Y; Meng Q; Zhang Y; Cheng Y; Wu G
Int Immunopharmacol; 2023 Nov; 124(Pt B):111001. PubMed ID: 37804658
[TBL] [Abstract][Full Text] [Related]
6. The short-chain fatty acids butyrate and propionate protect against inflammation-induced activation of mediators involved in active labor: implications for preterm birth.
Moylan HEC; Nguyen-Ngo C; Lim R; Lappas M
Mol Hum Reprod; 2020 Jun; 26(6):452-468. PubMed ID: 32236411
[TBL] [Abstract][Full Text] [Related]
7. Short-Chain Fatty Acids Promote Intracellular Bactericidal Activity in Head Kidney Macrophages From Turbot (
Zhang J; Zhang H; Liu M; Lan Y; Sun H; Mai K; Wan M
Front Immunol; 2020; 11():615536. PubMed ID: 33424870
[TBL] [Abstract][Full Text] [Related]
8. ASTRAGALOSIDE Ⅳ MODULATES GUT MACROPHAGES M1/M2 POLARIZATION BY RESHAPING GUT MICROBIOTA AND SHORT CHAIN FATTY ACIDS IN SEPSIS.
Yang T; Xie S; Cao L; Li M; Ding L; Wang L; Pang S; Wang Z; Geng L
Shock; 2024 Jan; 61(1):120-131. PubMed ID: 37962207
[TBL] [Abstract][Full Text] [Related]
9. Short-chain fatty acids inhibit the activation of T lymphocytes and myeloid cells and induce innate immune tolerance.
Porbahaie M; Hummel A; Saouadogo H; Coelho RML; Savelkoul HFJ; Teodorowicz M; van Neerven RJJ
Benef Microbes; 2023 Sep; 14(4):401-419. PubMed ID: 38661366
[TBL] [Abstract][Full Text] [Related]
10. Immunomodulatory potential of gut microbiome-derived short-chain fatty acids (SCFAs).
Ratajczak W; Rył A; Mizerski A; Walczakiewicz K; Sipak O; Laszczyńska M
Acta Biochim Pol; 2019 Mar; 66(1):1-12. PubMed ID: 30831575
[TBL] [Abstract][Full Text] [Related]
11. [Research Progress in Regulation of Allergic Diseases by Short-Chain Fatty Acids].
Shi YB; Gao SJ; Wang H
Sichuan Da Xue Xue Bao Yi Xue Ban; 2022 Jan; 53(1):28-34. PubMed ID: 35048596
[TBL] [Abstract][Full Text] [Related]
12. Short-chain fatty acids: microbial metabolites that alleviate stress-induced brain-gut axis alterations.
van de Wouw M; Boehme M; Lyte JM; Wiley N; Strain C; O'Sullivan O; Clarke G; Stanton C; Dinan TG; Cryan JF
J Physiol; 2018 Oct; 596(20):4923-4944. PubMed ID: 30066368
[TBL] [Abstract][Full Text] [Related]
13. Chronically Elevated Levels of Short-Chain Fatty Acids Induce T Cell-Mediated Ureteritis and Hydronephrosis.
Park J; Goergen CJ; HogenEsch H; Kim CH
J Immunol; 2016 Mar; 196(5):2388-400. PubMed ID: 26819206
[TBL] [Abstract][Full Text] [Related]
14. Systemic availability and metabolism of colonic-derived short-chain fatty acids in healthy subjects: a stable isotope study.
Boets E; Gomand SV; Deroover L; Preston T; Vermeulen K; De Preter V; Hamer HM; Van den Mooter G; De Vuyst L; Courtin CM; Annaert P; Delcour JA; Verbeke KA
J Physiol; 2017 Jan; 595(2):541-555. PubMed ID: 27510655
[TBL] [Abstract][Full Text] [Related]
15. Roles of Short-Chain Fatty Acids in Inflammatory Bowel Disease.
Shin Y; Han S; Kwon J; Ju S; Choi TG; Kang I; Kim SS
Nutrients; 2023 Oct; 15(20):. PubMed ID: 37892541
[TBL] [Abstract][Full Text] [Related]
16. The reduced SCFA-producing gut microbes are involved in the inflammatory activation in Kawasaki disease.
Wang F; Qian F; Zhang Q; Zhao J; Cen J; Zhang J; Zhou J; Luo M; Jia C; Rong X; Chu M
Front Immunol; 2023; 14():1124118. PubMed ID: 37398673
[TBL] [Abstract][Full Text] [Related]
17. The emerging role of microbiota-derived short-chain fatty acids in immunometabolism.
Abdalkareem Jasim S; Jade Catalan Opulencia M; Alexis Ramírez-Coronel A; Kamal Abdelbasset W; Hasan Abed M; Markov A; Raheem Lateef Al-Awsi G; Azamatovich Shamsiev J; Thaeer Hammid A; Nader Shalaby M; Karampoor S; Mirzaei R
Int Immunopharmacol; 2022 Sep; 110():108983. PubMed ID: 35750016
[TBL] [Abstract][Full Text] [Related]
18. Microbiota-derived short-chain fatty acids and modulation of host-derived peptides formation: Focused on host defense peptides.
Liu T; Sun Z; Yang Z; Qiao X
Biomed Pharmacother; 2023 Jun; 162():114586. PubMed ID: 36989711
[TBL] [Abstract][Full Text] [Related]
19. Benefits of short-chain fatty acids and their receptors in inflammation and carcinogenesis.
Sivaprakasam S; Prasad PD; Singh N
Pharmacol Ther; 2016 Aug; 164():144-51. PubMed ID: 27113407
[TBL] [Abstract][Full Text] [Related]
20. Short Chain Fatty Acids: Fundamental mediators of the gut-lung axis and their involvement in pulmonary diseases.
Ashique S; De Rubis G; Sirohi E; Mishra N; Rihan M; Garg A; Reyes RJ; Manandhar B; Bhatt S; Jha NK; Singh TG; Gupta G; Singh SK; Chellappan DK; Paudel KR; Hansbro PM; Oliver BG; Dua K
Chem Biol Interact; 2022 Dec; 368():110231. PubMed ID: 36288778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
